世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

詳細検索

お問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/20 10:26

155.91 円

165.77 円

200.60 円

ALL 市場調査レポート

このリストでは当社が提供する全市場調査レポートを新刊順に紹介しています。
通信・IT、環境・エネルギー・自動車だけでなく、医薬、医療、産業機械、電子部品/半導体、マテリアルを始めとして、運輸、金融・保険、農業・林業、消費財、不動産、宇宙・防衛、食品、小売業、サービス業等に関する調査レポート(技術動向、市場規模予測)を紹介しています。

筋層浸潤性膀胱がん (MIBC) (腫瘍学) - 開発段階の治療薬 2021年
Muscle Invasive Bladder Cancer (MIBC) (Oncology) - Drugs in Development, 2021
価格 US$ 2,000 |  Global Markets Direct | ―
Muscle Invasive Bladder Cancer (MIBC) (Oncology) - Drugs in Development, 2021SummaryMuscle Invasive Bladder Cancer (MIBC) (Oncology) - Drugs in Development, 2021 provides an overview of the Muscle Invasive Bladder Cancer (MIBC) pipeline landscape.The repo…
このレポートの詳細ページはこちら
筋骨格痛 (中枢神経系) - 開発段階の治療薬 2021年
Musculoskeletal Pain (Central Nervous System) - Drugs in Development, 2021
価格 US$ 2,000 |  Global Markets Direct | ―
Musculoskeletal Pain (Central Nervous System) - Drugs in Development, 2021SummaryMusculoskeletal Pain (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Musculoskeletal Pain pipeline landscape.The report provides comprehensi…
このレポートの詳細ページはこちら
筋強直性ジストロフィー (筋骨格) - 開発段階の治療薬 2021年
Myotonic Dystrophy (Musculoskeletal) - Drugs in Development, 2021
価格 US$ 2,000 |  Global Markets Direct | ―
Myotonic Dystrophy (Musculoskeletal) - Drugs in Development, 2021SummaryMyotonic Dystrophy (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Myotonic Dystrophy pipeline landscape.The report provides comprehensive information on th…
このレポートの詳細ページはこちら
禁煙 (中枢神経系) - 開発段階の治療薬 2021年
Smoking Cessation (Central Nervous System) - Drugs in Development, 2021
価格 US$ 2,000 |  Global Markets Direct | ―
Smoking Cessation (Central Nervous System) - Drugs in Development, 2021SummarySmoking Cessation (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Smoking Cessation pipeline landscape.The report provides comprehensive inform…
このレポートの詳細ページはこちら
胸腺がん (腫瘍学) - 開発段階の治療薬 2021年
Thymic Carcinoma (Oncology) - Drugs in Development, 2021
価格 US$ 2,000 |  Global Markets Direct | ―
Thymic Carcinoma (Oncology) - Drugs in Development, 2021SummaryThymic Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Thymic Carcinoma pipeline landscape.The report provides comprehensive information on the therapeutics under…
このレポートの詳細ページはこちら
急性肺障害 (呼吸器) - 開発段階の治療薬 2021年
Acute Lung Injury (Respiratory) - Drugs in Development, 2021
価格 US$ 2,000 |  Global Markets Direct | ―
Acute Lung Injury (Respiratory) - Drugs in Development, 2021SummaryAcute Lung Injury (Respiratory) - Drugs in Development, 2021 provides an overview of the Acute Lung Injury pipeline landscape.The report provides comprehensive information on the therapeut…
このレポートの詳細ページはこちら
急性心不全 (循環器) - 開発段階の治療薬 2021年
Acute Heart Failure (Cardiovascular) - Drugs in Development, 2021
価格 US$ 2,000 |  Global Markets Direct | ―
Acute Heart Failure (Cardiovascular) - Drugs in Development, 2021SummaryAcute Heart Failure (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Acute Heart Failure pipeline landscape.The report provides comprehensive information on t…
このレポートの詳細ページはこちら
急性虚血性脳卒中 (中枢神経系) - 開発段階の治療薬 2021年
Acute Ischemic Stroke (Central Nervous System) - Drugs in Development, 2021
価格 US$ 2,000 |  Global Markets Direct | ―
Acute Ischemic Stroke (Central Nervous System) - Drugs in Development, 2021SummaryAcute Ischemic Stroke (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Acute Ischemic Stroke pipeline landscape.The report provides comprehe…
このレポートの詳細ページはこちら
急性感音性難聴 (耳鼻咽喉科疾患) - 開発段階の治療薬 2021年
Acute Sensorineural Hearing Loss (Ear Nose Throat Disorders) - Drugs in Development, 2021
価格 US$ 2,000 |  Global Markets Direct | ―
Acute Sensorineural Hearing Loss (Ear Nose Throat Disorders) - Drugs in Development, 2021SummaryAcute Sensorineural Hearing Loss (Ear Nose Throat Disorders) - Drugs in Development, 2021 provides an overview of the Acute Sensorineural Hearing Loss pipeline…
このレポートの詳細ページはこちら
急性冠症候群 (循環器) - 開発段階の治療薬 2021年
Acute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021
価格 US$ 2,000 |  Global Markets Direct | ―
Acute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021SummaryAcute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Acute Coronary Syndrome pipeline landscape.The report provides comprehensive info…
このレポートの詳細ページはこちら
記憶障害 (中枢神経系) - 開発段階の治療薬 2021年
Memory Impairment (Central Nervous System) - Drugs in Development, 2021
価格 US$ 2,000 |  Global Markets Direct | ―
Memory Impairment (Central Nervous System) - Drugs in Development, 2021SummaryMemory Impairment (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Memory Impairment pipeline landscape.The report provides comprehensive inform…
このレポートの詳細ページはこちら
季節性インフルエンザ (感染性疾患) - 開発段階の治療薬 2021年
Seasonal Influenza (Infectious Disease) - Drugs in Development, 2021
価格 US$ 2,000 |  Global Markets Direct | ―
Seasonal Influenza (Infectious Disease) - Drugs in Development, 2021SummarySeasonal Influenza (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Seasonal Influenza pipeline landscape.The report provides comprehensive information…
このレポートの詳細ページはこちら
季節性アレルギー性鼻炎 (呼吸器) - 開発段階の治療薬 2021年
Seasonal Allergic Rhinitis (Respiratory) - Drugs in Development, 2021
価格 US$ 2,000 |  Global Markets Direct | ―
Seasonal Allergic Rhinitis (Respiratory) - Drugs in Development, 2021SummarySeasonal Allergic Rhinitis (Respiratory) - Drugs in Development, 2021 provides an overview of the Seasonal Allergic Rhinitis pipeline landscape.The report provides comprehensive i…
このレポートの詳細ページはこちら
眼痛 (中枢神経系) - 開発段階の治療薬 2021年
Ocular Pain (Eye Pain) (Central Nervous System) - Drugs in Development, 2021
価格 US$ 2,000 |  Global Markets Direct | ―
Ocular Pain (Eye Pain) (Central Nervous System) - Drugs in Development, 2021SummaryOcular Pain (Eye Pain) (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Ocular Pain (Eye Pain) pipeline landscape.The report provides compr…
このレポートの詳細ページはこちら
肝臓がん (腫瘍学) - 開発段階の治療薬 2021年
Liver Cancer (Oncology) - Drugs in Development, 2021
価格 US$ 2,500 |  Global Markets Direct | ―
Liver Cancer (Oncology) - Drugs in Development, 2021SummaryLiver Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Liver Cancer pipeline landscape.The report provides comprehensive information on the therapeutics under development…
このレポートの詳細ページはこちら
肝線維症 (胃腸) - 開発段階の治療薬 2021年
Liver Fibrosis (Gastrointestinal) - Drugs in Development, 2021
価格 US$ 2,500 |  Global Markets Direct | ―
Liver Fibrosis (Gastrointestinal) - Drugs in Development, 2021SummaryLiver Fibrosis (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Liver Fibrosis pipeline landscape.The report provides comprehensive information on the therapeu…
このレポートの詳細ページはこちら
肝外胆管がん (腫瘍学) - 開発段階の治療薬 2021年
Extrahepatic Bile Duct Cancer (Oncology) - Drugs in Development, 2021
価格 US$ 2,000 |  Global Markets Direct | ―
Extrahepatic Bile Duct Cancer (Oncology) - Drugs in Development, 2021SummaryExtrahepatic Bile Duct Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Extrahepatic Bile Duct Cancer pipeline landscape.The report provides comprehensiv…
このレポートの詳細ページはこちら
冠動脈疾患 (CAD) (虚血性心疾患) (循環器) - 開発段階の治療薬 2021年
Coronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) - Drugs in Development, 2021
価格 US$ 2,000 |  Global Markets Direct | ―
Coronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) - Drugs in Development, 2021SummaryCoronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Coronary Artery Dis…
このレポートの詳細ページはこちら
角膜移植拒絶反応 (免疫学) - 開発段階の治療薬 2021年
Corneal Graft Rejection (Immunology) - Drugs in Development, 2021
価格 US$ 2,000 |  Global Markets Direct | ―
Corneal Graft Rejection (Immunology) - Drugs in Development, 2021SummaryCorneal Graft Rejection (Immunology) - Drugs in Development, 2021 provides an overview of the Corneal Graft Rejection pipeline landscape.The report provides comprehensive information …
このレポートの詳細ページはこちら
外傷 (心的外傷) (その他の疾患) - 開発段階の治療薬 2021年
Trauma (Other Diseases) - Drugs in Development, 2021
価格 US$ 2,000 |  Global Markets Direct | ―
Trauma (Other Diseases) - Drugs in Development, 2021SummaryTrauma (Other Diseases) - Drugs in Development, 2021 provides an overview of the Trauma pipeline landscape.The report provides comprehensive information on the therapeutics under development for T…
このレポートの詳細ページはこちら
カテゴリ別にレポートを見る

ページTOPに戻る